-+ 0.00%
-+ 0.00%
-+ 0.00%

Arbutus Biopharma Gets FDA Fast-Track Designation for Imdusiran in Chronic Hepatitis B

Dow Jones·04/15/2026 12:05:00

Please log in to view news